Intuitive Surgical, Inc. (NASDAQ:ISRG) Holdings Increased by Waldron Private Wealth LLC

Waldron Private Wealth LLC lifted its stake in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 25.2% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 3,064 shares of the medical equipment provider’s stock after acquiring an additional 617 shares during the quarter. Waldron Private Wealth LLC’s holdings in Intuitive Surgical were worth $1,599,000 at the end of the most recent reporting period.

Several other hedge funds and other institutional investors have also recently added to or reduced their stakes in ISRG. Bennett Selby Investments LP raised its stake in shares of Intuitive Surgical by 3.9% in the 4th quarter. Bennett Selby Investments LP now owns 449 shares of the medical equipment provider’s stock worth $234,000 after buying an additional 17 shares in the last quarter. LVW Advisors LLC boosted its holdings in Intuitive Surgical by 1.3% during the fourth quarter. LVW Advisors LLC now owns 1,448 shares of the medical equipment provider’s stock worth $756,000 after buying an additional 19 shares in the last quarter. Wesbanco Bank Inc. grew its position in Intuitive Surgical by 1.6% in the fourth quarter. Wesbanco Bank Inc. now owns 1,216 shares of the medical equipment provider’s stock worth $635,000 after buying an additional 19 shares during the last quarter. Hazlett Burt & Watson Inc. lifted its position in shares of Intuitive Surgical by 5.8% during the 3rd quarter. Hazlett Burt & Watson Inc. now owns 362 shares of the medical equipment provider’s stock valued at $177,000 after acquiring an additional 20 shares during the last quarter. Finally, Mitchell Mcleod Pugh & Williams Inc. boosted its stake in shares of Intuitive Surgical by 4.1% during the 3rd quarter. Mitchell Mcleod Pugh & Williams Inc. now owns 503 shares of the medical equipment provider’s stock worth $247,000 after acquiring an additional 20 shares in the last quarter. Institutional investors own 83.64% of the company’s stock.

Insiders Place Their Bets

In other news, insider Jamie Samath sold 22,903 shares of the firm’s stock in a transaction that occurred on Friday, November 8th. The shares were sold at an average price of $525.00, for a total transaction of $12,024,075.00. Following the completion of the sale, the insider now owns 8,757 shares of the company’s stock, valued at approximately $4,597,425. This trade represents a 72.34 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is accessible through this link. Also, EVP Robert Desantis sold 376 shares of the firm’s stock in a transaction on Friday, November 29th. The shares were sold at an average price of $539.00, for a total value of $202,664.00. Following the sale, the executive vice president now directly owns 5,506 shares of the company’s stock, valued at $2,967,734. This represents a 6.39 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold 28,843 shares of company stock worth $15,357,560 over the last 90 days. Corporate insiders own 0.90% of the company’s stock.

Analysts Set New Price Targets

A number of equities research analysts have recently issued reports on the company. Evercore ISI boosted their target price on Intuitive Surgical from $490.00 to $530.00 in a research report on Monday, January 27th. JPMorgan Chase & Co. upped their price objective on shares of Intuitive Surgical from $575.00 to $675.00 and gave the company an “overweight” rating in a research note on Friday, January 24th. Raymond James boosted their price target on shares of Intuitive Surgical from $560.00 to $688.00 and gave the company an “outperform” rating in a report on Friday, January 24th. Robert W. Baird increased their target price on Intuitive Surgical from $503.00 to $565.00 and gave the company an “outperform” rating in a report on Thursday, October 17th. Finally, Barclays lifted their price target on Intuitive Surgical from $610.00 to $674.00 in a report on Monday, January 27th. One analyst has rated the stock with a sell rating, five have issued a hold rating and sixteen have issued a buy rating to the stock. Based on data from MarketBeat.com, Intuitive Surgical currently has an average rating of “Moderate Buy” and an average target price of $613.10.

Intuitive Surgical Trading Down 1.4 %

Shares of NASDAQ:ISRG opened at $571.88 on Friday. The business’s 50 day moving average is $549.92 and its 200-day moving average is $508.00. The firm has a market capitalization of $203.69 billion, a PE ratio of 89.22, a PEG ratio of 5.52 and a beta of 1.39. Intuitive Surgical, Inc. has a 1-year low of $364.17 and a 1-year high of $616.00.

Intuitive Surgical Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.